Anti-nucleocapsid Antibody Response After Two Doses of CoronaVac® Among Healthcare Workers
Introduction: The Coronavirus disease-2019 (COVID-19) pandemic that started over two years ago has led to high mortality and morbidity. Vaccine studies have been initiated worldwide to end the pandemic, and the CoronaVac® vaccine was first administered to healthcare workers at high risk of COVID-19...
| Published in: | Mediterranean Journal of Infection, Microbes and Antimicrobials |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Infectious Diseases and Clinical Microbiology Specialty Society of Turkey
2022-05-01
|
| Subjects: | |
| Online Access: | http://mjima.org/text.php?&id=322 |
